Is THMO or TBIO more profitable?

ThermoGenesis has a net margin of 0.00% compared to Telesis Bio's net margin of -336.59%. Company Net Margins Return on Equity Return on Assets ThermoGenesis N/A N/A N/A Telesis Bio -336.59% N/A -61.89%

Is HTGMQ or TBIO more profitable?

HTG Molecular Diagnostics has a net margin of 0.00% compared to Telesis Bio's net margin of -336.59%. Company Net Margins Return on Equity Return on Assets HTG Molecular Diagnostics N/A N/A N/A Telesis Bio -336.59% N/A -61.89%

Which has preferable earnings and valuation, OLITW or TBIO?

OmniLit Acquisition has higher earnings, but lower revenue than Telesis Bio. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio OmniLit Acquisition N/A N/A N/A N/A N/A Telesis Bio $225.09M 0.00 -$47.72M -$20.52 N/A

Is OLITW or TBIO more profitable?

OmniLit Acquisition has a net margin of 0.00% compared to Telesis Bio's net margin of -336.59%. Company Net Margins Return on Equity Return on Assets OmniLit Acquisition N/A N/A N/A Telesis Bio -336.59% N/A -61.89%

Which has preferable valuation & earnings, TBIO or PRENW?

Prenetics Global has lower revenue, but higher earnings than Telesis Bio. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Telesis Bio $225.09M 0.00 -$47.72M -$20.52 N/A Prenetics Global $120.07M N/A N/A N/A N/A

Is TBIO or PRENW more profitable?

Prenetics Global has a net margin of 0.00% compared to Telesis Bio's net margin of -336.59%. Company Net Margins Return on Equity Return on Assets Telesis Bio -336.59% N/A -61.89% Prenetics Global N/A N/A N/A

Which has higher earnings and valuation, TBIO or QSIAW?

Quantum-Si has lower revenue, but higher earnings than Telesis Bio. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Telesis Bio $225.09M 0.00 -$47.72M -$20.52 N/A Quantum-Si $1.85M N/A N/A N/A N/A

Is TBIO or QSIAW more profitable?

Quantum-Si has a net margin of 0.00% compared to Telesis Bio's net margin of -336.59%. Company Net Margins Return on Equity Return on Assets Telesis Bio -336.59% N/A -61.89% Quantum-Si N/A N/A N/A

Telesis Bio (TBIO) Competitors

$0.0010 0.00 (0.00%)

As of 06/30/2026

Compare

TBIO vs. THMO, HTGMQ, OLITW, PRENW, and QSIAW

Should you buy Telesis Bio stock or one of its competitors? MarketBeat compares Telesis Bio with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Telesis Bio include ThermoGenesis (THMO), HTG Molecular Diagnostics (HTGMQ), OmniLit Acquisition (OLITW), Prenetics Global (PRENW), and Quantum-Si (QSIAW). These companies are all part of the "measuring and control equipment" industry.

How does Telesis Bio compare to ThermoGenesis?

ThermoGenesis (NASDAQ:THMO) and Telesis Bio (NASDAQ:TBIO) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, dividends, media sentiment, analyst recommendations, risk, institutional ownership, profitability and earnings.

In the previous week, ThermoGenesis' average media sentiment score of 0.00 equaled Telesis Bio'saverage media sentiment score.

Company	Overall Sentiment
ThermoGenesis	Neutral
Telesis Bio	Neutral

5.8% of ThermoGenesis shares are owned by institutional investors. Comparatively, 37.6% of Telesis Bio shares are owned by institutional investors. 78.0% of ThermoGenesis shares are owned by insiders. Comparatively, 24.5% of Telesis Bio shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

ThermoGenesis has higher earnings, but lower revenue than Telesis Bio. Telesis Bio is trading at a lower price-to-earnings ratio than ThermoGenesis, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
ThermoGenesis	$9.61M	0.00	-$17.98M	-$5.14	N/A
Telesis Bio	$225.09M	0.00	-$47.72M	-$20.52	N/A

ThermoGenesis has a net margin of 0.00% compared to Telesis Bio's net margin of -336.59%.

Company	Net Margins	Return on Equity	Return on Assets
ThermoGenesis	N/A	N/A	N/A
Telesis Bio	-336.59%	N/A	-61.89%

ThermoGenesis has a beta of 1.13, suggesting that its stock price is 13% more volatile than the broader market. Comparatively, Telesis Bio has a beta of 2.27, suggesting that its stock price is 127% more volatile than the broader market.

Summary

ThermoGenesis beats Telesis Bio on 7 of the 10 factors compared between the two stocks.

How does Telesis Bio compare to HTG Molecular Diagnostics?

HTG Molecular Diagnostics (NASDAQ:HTGMQ) and Telesis Bio (NASDAQ:TBIO) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their valuation, institutional ownership, analyst recommendations, profitability, dividends, risk, media sentiment and earnings.

HTG Molecular Diagnostics has a beta of 3.06, indicating that its share price is 206% more volatile than the broader market. Comparatively, Telesis Bio has a beta of 2.27, indicating that its share price is 127% more volatile than the broader market.

HTG Molecular Diagnostics has higher earnings, but lower revenue than Telesis Bio. Telesis Bio is trading at a lower price-to-earnings ratio than HTG Molecular Diagnostics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
HTG Molecular Diagnostics	$6.37M	0.00	-$21.59M	-$2.28	N/A
Telesis Bio	$225.09M	0.00	-$47.72M	-$20.52	N/A

37.6% of Telesis Bio shares are owned by institutional investors. 2.6% of HTG Molecular Diagnostics shares are owned by insiders. Comparatively, 24.5% of Telesis Bio shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

In the previous week, HTG Molecular Diagnostics' average media sentiment score of 0.00 equaled Telesis Bio'saverage media sentiment score.

Company	Overall Sentiment
HTG Molecular Diagnostics	Neutral
Telesis Bio	Neutral

HTG Molecular Diagnostics has a net margin of 0.00% compared to Telesis Bio's net margin of -336.59%.

Company	Net Margins	Return on Equity	Return on Assets
HTG Molecular Diagnostics	N/A	N/A	N/A
Telesis Bio	-336.59%	N/A	-61.89%

Summary

HTG Molecular Diagnostics beats Telesis Bio on 5 of the 9 factors compared between the two stocks.

How does Telesis Bio compare to OmniLit Acquisition?

OmniLit Acquisition (NASDAQ:OLITW) and Telesis Bio (NASDAQ:TBIO) are both measuring and control equipment companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, risk, media sentiment, valuation, earnings, institutional ownership, analyst recommendations and dividends.

OmniLit Acquisition has higher earnings, but lower revenue than Telesis Bio.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
OmniLit Acquisition	N/A	N/A	N/A	N/A	N/A
Telesis Bio	$225.09M	0.00	-$47.72M	-$20.52	N/A

OmniLit Acquisition has a net margin of 0.00% compared to Telesis Bio's net margin of -336.59%.

Company	Net Margins	Return on Equity	Return on Assets
OmniLit Acquisition	N/A	N/A	N/A
Telesis Bio	-336.59%	N/A	-61.89%

37.6% of Telesis Bio shares are held by institutional investors. 24.5% of Telesis Bio shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

In the previous week, OmniLit Acquisition's average media sentiment score of 0.00 equaled Telesis Bio'saverage media sentiment score.

Company	Overall Sentiment
OmniLit Acquisition	Neutral
Telesis Bio	Neutral

Summary

Telesis Bio beats OmniLit Acquisition on 3 of the 5 factors compared between the two stocks.

How does Telesis Bio compare to Prenetics Global?

Telesis Bio (NASDAQ:TBIO) and Prenetics Global (NASDAQ:PRENW) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, risk, earnings, analyst recommendations, valuation, dividends, media sentiment and institutional ownership.

Prenetics Global has a net margin of 0.00% compared to Telesis Bio's net margin of -336.59%.

Company	Net Margins	Return on Equity	Return on Assets
Telesis Bio	-336.59%	N/A	-61.89%
Prenetics Global	N/A	N/A	N/A

In the previous week, Prenetics Global had 1 more articles in the media than Telesis Bio. MarketBeat recorded 1 mentions for Prenetics Global and 0 mentions for Telesis Bio. Prenetics Global's average media sentiment score of 1.89 beat Telesis Bio's score of 0.00 indicating that Prenetics Global is being referred to more favorably in the news media.

Company	Overall Sentiment
Telesis Bio	Neutral
Prenetics Global	Very Positive

37.6% of Telesis Bio shares are owned by institutional investors. 24.5% of Telesis Bio shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Prenetics Global has lower revenue, but higher earnings than Telesis Bio.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Telesis Bio	$225.09M	0.00	-$47.72M	-$20.52	N/A
Prenetics Global	$120.07M	N/A	N/A	N/A	N/A

Summary

Prenetics Global beats Telesis Bio on 4 of the 7 factors compared between the two stocks.

How does Telesis Bio compare to Quantum-Si?

Telesis Bio (NASDAQ:TBIO) and Quantum-Si (NASDAQ:QSIAW) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, analyst recommendations, media sentiment, dividends, valuation, risk, profitability and institutional ownership.

In the previous week, Telesis Bio's average media sentiment score of 0.00 equaled Quantum-Si'saverage media sentiment score.

Company	Overall Sentiment
Telesis Bio	Neutral
Quantum-Si	Neutral

37.6% of Telesis Bio shares are held by institutional investors. 24.5% of Telesis Bio shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Quantum-Si has lower revenue, but higher earnings than Telesis Bio.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Telesis Bio	$225.09M	0.00	-$47.72M	-$20.52	N/A
Quantum-Si	$1.85M	N/A	N/A	N/A	N/A

Quantum-Si has a net margin of 0.00% compared to Telesis Bio's net margin of -336.59%.

Company	Net Margins	Return on Equity	Return on Assets
Telesis Bio	-336.59%	N/A	-61.89%
Quantum-Si	N/A	N/A	N/A

Summary

Telesis Bio beats Quantum-Si on 3 of the 5 factors compared between the two stocks.

Get Telesis Bio News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding TBIO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

TBIO vs. The Competition

Export

Metric	Telesis Bio	Analytical instruments Industry	Medical Sector	NASDAQ Exchange
Market Cap	$2K	$2K	$6.79B	$12.54B
Dividend Yield	N/A	N/A	2.66%	6.15%
P/E Ratio	0.00	N/A	27.46	25.27
Price / Sales	0.00	0.00	582.89	119.23
Price / Cash	N/A	N/A	48.53	58.59
Price / Book	0.01	0.01	10.95	6.61
Net Income	-$47.72M	-$47.72M	$3.57B	$336.83M
7 Day Performance	N/A	N/A	2.58%	2.52%
1 Month Performance	N/A	N/A	1.67%	0.44%
1 Year Performance	N/A	N/A	35.96%	29.40%

Telesis Bio Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
TBIO Telesis Bio	N/A	$0.00 flat	N/A	N/A	$2K	$225.09M	N/A	200
THMO ThermoGenesis	N/A	N/A	N/A	N/A	$1K	$9.61M	N/A	40
HTGMQ HTG Molecular Diagnostics	N/A	$0.00 flat	N/A	N/A	$0.00	$6.37M	N/A	90
OLITW OmniLit Acquisition	N/A	$1.67 flat	N/A	N/A	$0.00	N/A	N/A	3	Gap Up
PRENW Prenetics Global	N/A	$0.01 flat	N/A	-66.8%	$0.00	$120.07M	N/A	1

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:TBIO) was last updated on 7/1/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Telesis Bio (TBIO) Competitors

TBIO vs. THMO, HTGMQ, OLITW, PRENW, and QSIAW

How does Telesis Bio compare to ThermoGenesis?

Summary

How does Telesis Bio compare to HTG Molecular Diagnostics?

Summary

How does Telesis Bio compare to OmniLit Acquisition?

Summary

How does Telesis Bio compare to Prenetics Global?

Summary

How does Telesis Bio compare to Quantum-Si?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

TBIO vs. The Competition

Telesis Bio Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Telesis Bio (TBIO) Competitors

TBIO vs. THMO, HTGMQ, OLITW, PRENW, and QSIAW

How does Telesis Bio compare to ThermoGenesis?

Does the media prefer THMO or TBIO?

Do insiders and institutionals have more ownership in THMO or TBIO?

Which has higher earnings & valuation, THMO or TBIO?

Is THMO or TBIO more profitable?

Which has more volatility & risk, THMO or TBIO?

Summary

How does Telesis Bio compare to HTG Molecular Diagnostics?

Which has more risk & volatility, HTGMQ or TBIO?

Which has better earnings & valuation, HTGMQ or TBIO?

Do institutionals & insiders hold more shares of HTGMQ or TBIO?

Does the media prefer HTGMQ or TBIO?

Is HTGMQ or TBIO more profitable?

Summary

How does Telesis Bio compare to OmniLit Acquisition?

Which has preferable earnings and valuation, OLITW or TBIO?

Is OLITW or TBIO more profitable?

Do insiders and institutionals hold more shares of OLITW or TBIO?

Does the media favor OLITW or TBIO?

Summary

How does Telesis Bio compare to Prenetics Global?

Is TBIO or PRENW more profitable?

Does the media refer more to TBIO or PRENW?

Do institutionals and insiders have more ownership in TBIO or PRENW?

Which has preferable valuation & earnings, TBIO or PRENW?

Summary

How does Telesis Bio compare to Quantum-Si?

Does the media prefer TBIO or QSIAW?

Do insiders & institutionals believe in TBIO or QSIAW?

Which has higher earnings and valuation, TBIO or QSIAW?

Is TBIO or QSIAW more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

TBIO vs. The Competition

Telesis Bio Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools